Fractional BNT162b2 boosters induce durable immune responses after non-mRNA priming in Mongolia: a randomised controlled trial.
Saved in:
| Title: | Fractional BNT162b2 boosters induce durable immune responses after non-mRNA priming in Mongolia: a randomised controlled trial. |
|---|---|
| Authors: | Batmunkh T; National Centre for Communicable Diseases, Ulaanbaatar, Mongolia., Neal EF; Infection, Immunity, and Global Health, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Australia., Amraa O; National Centre for Communicable Diseases, Ulaanbaatar, Mongolia., Mazarakis N; Infection, Immunity, and Global Health, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Australia., Altangerel B; Onoshmed Laboratory, Sukhbaatar District, Ulaanbaatar, Mongolia., Avaa N; Onoshmed Laboratory, Sukhbaatar District, Ulaanbaatar, Mongolia., Batbayar L; Sukhbaatar District Health Centre, Ulaanbaatar, Mongolia., Batsukh K; General Laboratory of Clinical Pathology, First Central Hospital of Mongolia, Ulaanbaatar, Mongolia., Bright K; Infection, Immunity, and Global Health, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia., Burentogtokh T; General Laboratory of Clinical Pathology, First Central Hospital of Mongolia, Ulaanbaatar, Mongolia., Do LAH; Infection, Immunity, and Global Health, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Australia., Dorj G; Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia., Hart JD; Infection, Immunity, and Global Health, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Australia., Jamiyandorj O; City Health Department, Ulaanbaatar, Mongolia., Javkhlantugs K; Bayangol District Health Centre, Bayangol District, Ulaanbaatar, Mongolia., Jigjidsuren S; General Laboratory of Clinical Pathology, First Central Hospital of Mongolia, Ulaanbaatar, Mongolia., Justice F; Infection, Immunity, and Global Health, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia., Li S; Infection, Immunity, and Global Health, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia., Mashbaatar K; National Centre for Communicable Diseases, Ulaanbaatar, Mongolia., Moore KA; Infection, Immunity, and Global Health, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia., Namjil N; Onoshmed Laboratory, Sukhbaatar District, Ulaanbaatar, Mongolia., Nguyen CD; Infection, Immunity, and Global Health, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Australia., Ochirbat B; National Centre for Communicable Diseases, Ulaanbaatar, Mongolia., Surenjav U; National Centre for Public Health, Ulaanbaatar, Mongolia., Thomson H; Infection, Immunity, and Global Health, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia., Tsolmon B; National Centre for Communicable Diseases, Ulaanbaatar, Mongolia.; Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia., Licciardi PV; Infection, Immunity, and Global Health, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Australia., von Mollendorf C; Infection, Immunity, and Global Health, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia.; Department of Paediatrics, The University of Melbourne, Parkville, Australia., Mulholland K; Infection, Immunity, and Global Health, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Australia. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Mar 23; Vol. 17, pp. 1789248. Date of Electronic Publication: 2026 Mar 23 (Print Publication: 2026). |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1789248 |
